On December 10, 2024, Joseph Jimenez, an executive at Procter & Gamble, was granted 276 shares of common stock at a price of $0 per share. This transaction was reported as a direct acquisition under the transaction code 'A', indicating a grant, award, or other acquisition.Following this transaction, Jimenez's total beneficial ownership of Procter & Gamble common stock increased to 32,858.8078 shares, held directly. The acquisition was completed on the reported date, with no additional transactions mentioned in the filing.This stock grant appears to be part of the company's executive compensation or incentive program, as it was awarded at no cost to the recipient. Such grants are common practices among large corporations to align executive interests with those of shareholders.

On December 10, 2024, Joseph Jimenez, an executive at Procter & Gamble, was granted 276 shares of common stock at a price of $0 per share. This transaction was reported as a direct acquisition under the transaction code 'A', indicating a grant, award, or other acquisition.Following this transaction, Jimenez's total beneficial ownership of Procter & Gamble common stock increased to 32,858.8078 shares, held directly. The acquisition was completed on the reported date, with no additional transactions mentioned in the filing.This stock grant appears to be part of the company's executive compensation or incentive program, as it was awarded at no cost to the recipient. Such grants are common practices among large corporations to align executive interests with those of shareholders.